Human primary immunodeficiency caused by expression of a kinase-dead p110δ mutant

Authors

Sarah Beaussant Cohen, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Wayne Bainter, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Jared L. Johnson, Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Ting-Yu Lin, Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Jenny C. Y Wong, Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Jacqueline G. Wallace, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Jennifer Jones, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Sonia Qureshi, Aga Khan UniversityFollow
Fatima Mir, Aga Khan UniversityFollow
Farah Qamar, Aga Khan UniversityFollow

Document Type

Letter to the Editor

Department

Paediatrics and Child Health

Abstract

This case demonstrates the essential contribution of the p110δ catalytic 21 domain in adaptive immunity function in a patient with expression of a kinase-dead p110δ mutant.

Publication (Name of Journal)

Journal of Allergy and Clinical Immunology

Recommended Citation

Cohen, S. B., Bainter, W., Johnson, J. L., Lin, T., Y Wong, J. C., Wallace, J. G., Jones, J., Qureshi, S., Mir, F., Qamar, F. (2019). Human primary immunodeficiency caused by expression of a kinase-dead p110δ mutant. Journal of Allergy and Clinical Immunology, 143(2), 797-799.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/847